Sofosbuvir and Ribavirin in Treatment-Naive and Treatment-Experienced Subjects With Chronic Genotype 2 or 3 HCV Infection
Clinical trial NCT01682720 · COMPLETED
Trial details
- NCT number
- NCT01682720
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-01
- Primary completion
- 2013-10-01
- Enrollment
- 421
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.